๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Best Medical Management

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 5 trials in our China register that name Best Medical Management as an intervention. Synced 24 Sep 2026
5Trials tracked
2Recruiting now
5Lead sponsors
1Country register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

Best Medical Management is named as a drug or biological intervention in 5 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Beijing Tiantan Hospital (1), The First Affiliated Hospital with Nanjing Medical University (1) and Capital Medical University (1). Registered phases: Not applicable and Phase 3. Conditions studied include Acute Basilar Artery Occlusion; Endovascular Therapy; Large Core Infarction.

01

Clinical trials of Best Medical Management

5 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT06559241 Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy๏ผˆRECAST-MT๏ผ‰ (ClinicalTrials.gov ↗)
Acute Ischemic Stroke, Anterior Circulation Brain Infarction
Phase 3 Recruiting Capital Medical University China
NCT06155032 Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion (ClinicalTrials.gov ↗)
Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
Not applicable Recruiting First Affiliated Hospital of Wannan Medical College China
NCT07668323 Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion (ClinicalTrials.gov ↗)
Medium Vessel Occlusion, Ischemic Stroke, Acute
Phase 3 Not yet open The First Affiliated Hospital with Nanjing Medical University China
NCT07333950 The Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Due to Large Core Infarction (ClinicalTrials.gov ↗)
Acute Basilar Artery Occlusion, Endovascular Therapy, Large Core Infarction
Not applicable Not yet open Beijing Tiantan Hospital China
NCT07390032 The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion (ClinicalTrials.gov ↗)
Acute Mild Basilar Artery Occlusion, Basilar Artery Occlusion, Endovascular Treatment
Not applicable Not yet open Feng Gao China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

12 conditions
Condition (as registered)Trials
Acute Basilar Artery Occlusion1
Endovascular Therapy1
Large Core Infarction1
Medium Vessel Occlusion1
Ischemic Stroke, Acute1
Acute Ischemic Stroke1
Anterior Circulation Brain Infarction1
Acute Mild Basilar Artery Occlusion1
Basilar Artery Occlusion1
Endovascular Treatment1
Stroke, Ischemic1
Cerebrovascular; Disorder, Occlusive1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Beijing Tiantan Hospital1
The First Affiliated Hospital with Nanjing Medical University1
Capital Medical University1
Feng Gao1
First Affiliated Hospital of Wannan Medical College1
04

Trials by country register

RegisterBest Medical Management trials
Clinical trials in China5

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Best Medical Management works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Best Medical Management (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.